Content about Pharmaceutical companies

July 22, 2010

Generic drug maker Par Pharmaceutical Cos. has appointed a former Roche executive to its board...

July 22, 2010

The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected...

SILVER SPRING, Md. The Food and Drug Administration has approved the first generic version of a Sanofi-Aventis injected drug used to treat deep vein thrombosis, the agency said Friday.

 

The FDA approved generic enoxaparin sodium, a version of Sanofi’s Lovenox, developed under a collaboration between Momenta Pharmaceuticals and Sandoz, the generics division of Swiss drug maker Novartis.

 

 

July 21, 2010

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 21, 2010

British drug maker GlaxoSmithKline is the latest company to join health policy research organization the...

July 20, 2010

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 20, 2010

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

July 20, 2010

Pfizer is selling one of its New York properties to financial services firm TIAA-CREF, according...

July 18, 2010

A U.S. District Court has ruled in favor of two companies who alleged patent infringement...

July 18, 2010

Biotechnology company Spectrum Pharmaceuticals has appointed a new SVP, chief scientific officer and head of...

July 15, 2010

German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...

July 15, 2010

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 14, 2010

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 14, 2010

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

July 13, 2010

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.

 

 

July 12, 2010

Timothy Hayes, currently SVP and region head for Bayer HealthCare's consumer care division in North...

July 11, 2010

Regional retail pharmacy chain Kerr Drug has hired former GlaxoSmithKline and Johnson & Johnson executive...

July 8, 2010

Roxane Labs announced Thursday the launch of two new generic drugs....

COLUMBUS, Ohio Roxane Labs announced Thursday the launch of two new generic drugs.

 

The Columbus, Ohio-based generics subsidiary of German drug maker Boehringer Ingelheim, launched naratriptan tablets in the 1-mg and 2.5-mg strengths, and anastrozole tablets in the 1-mg strength.

 

 

July 7, 2010

Merck will close down eight of its research and development sites and eight of its...

July 7, 2010

A big-ticket acquisition could be in the works for French drug maker Sanofi-Aventis, according to...

July 6, 2010

Launch and use of new heart drugs will drive the market for drugs to treat...

July 6, 2010

Dr. Reddy’s Labs has received approval from the Food and Drug Administration and launched three...

July 5, 2010

The Food and Drug Administration has approved a topical drug for acne made by E....

July 5, 2010

The Food and Drug Administration has approved a drug made by Watson Pharmaceuticals for treating...

June 30, 2010

British drug maker GlaxoSmithKline has inked a co-development and commercialization agreement with Genmab, the drug...

June 30, 2010

Sanofi-Aventis and the Juvenile Diabetes Research Foundation announced they jointly will develop therapeutic treatments for...